Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Nitrite SR for Pain in Knee Revision Arthroplasty
NCT05893160Phase 1Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules, Device-based Delivery
01
Overview
Phase 1, randomised, double-blind trial of JAN101 in postoperative pain (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoints: Opioid Requirements at 30 days, Short-form McGill Pain Questionnaire at 30 days and 9 more. Planned start Jun 2026; status: withdrawn.
02
Drugs
JAN101
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05893160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05893160.